We report a case of
hypercalcemia in a female patient who was restarted on
hemodialysis 22 years after
renal transplantation. Graft biopsy showed chronic post-transplant nephropathy. Treatment with
immunosuppressants and
steroids was maintained owing to residual graft function. She was then given oral paracalcitol 1 µg/d for
secondary hyperparathyroidism (iPTH 850 pg/mL) and her transplant medication was reduced and then discontinued. After this, the patient referred widespread
joint pain, especially in the hips and subsequently presented with
erythema nodosum. She also developed
hypercalcemia and
hyperphosphatemia which persisted after stopping paracalcitol. The clinical picture of increased serum
calcitriol, with depressed PTH, suggested
sarcoidosis, despite normal ACE levels, a chest X-ray and skin biopsy confirmed the diagnosis, and the patient was started on
prednisone 50 mg/day, resulting in prompt normalization of both symptoms and blood chemistry. This is a rare case of
hypercalcemia secondary to
sarcoidosis in an uremic patient. The
sarcoidosis was most likely suppressed by the transplant
therapy and rapidly developed after this was suspended. Prompt diagnosis resulted in a good therapeutic response.